Evidence map›Paper›PMID 32524363›Full record

ReviewCurrent heart failure reports2020

Coexisting Morbidities in Heart Failure: No Robust Interaction with the Left Ventricular Ejection Fraction.

Andrew Xanthopoulos, Apostolos Dimos, Grigorios Giamouzis, Angeliki Bourazana, Alexandros Zagouras, Michail Papamichalis, Takeshi Kitai, John Skoularigis, Filippos Triposkiadis

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current heart failure reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Andrew XanthopoulosDepartment of Cardiology, University General Hospital of Larissa, P.O. Box 1425, 411 10, Larissa, Greece.
Apostolos DimosDepartment of Cardiology, University General Hospital of Larissa, P.O. Box 1425, 411 10, Larissa, Greece.
Grigorios GiamouzisDepartment of Cardiology, University General Hospital of Larissa, P.O. Box 1425, 411 10, Larissa, Greece.
Angeliki BourazanaDepartment of Cardiology, University General Hospital of Larissa, P.O. Box 1425, 411 10, Larissa, Greece.
Alexandros ZagourasDepartment of Cardiology, University General Hospital of Larissa, P.O. Box 1425, 411 10, Larissa, Greece.
Michail PapamichalisDepartment of Cardiology, University General Hospital of Larissa, P.O. Box 1425, 411 10, Larissa, Greece.
Takeshi KitaiDepartments of Cardiovascular Medicine and Clinical Research Support, Kobe City Medical Center General Hospital, Kobe, Japan.
John SkoularigisDepartment of Cardiology, University General Hospital of Larissa, P.O. Box 1425, 411 10, Larissa, Greece.
Filippos TriposkiadisDepartment of Cardiology, University General Hospital of Larissa, P.O. Box 1425, 411 10, Larissa, Greece. ftriposkiadis@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewHeart failure (HF) patients often present with multiple coexisting morbidities. In this review, we contend that coexisting morbidities are highly prevalent and clinically important regardless of the left ventricular ejection fraction (LVEF). RECENT

findingsMultimorbidity is prevalent in the ambulatory subjects of the community and increases with age. Differences in the prevalence of coexisting morbidities between HF with preserved LVEF (> 50%), mid-range LVEF (40-50%), and reduced LVEF (< 40%) are either not demonstrable or whenever present are small and unrelated to morbidity and mortality. The constellation of coexisting morbidities together with the disease modifiers (age, sex, genes, other) defines the HF phenotype and outcome. There is no robust evidence supporting an interaction in HF patients between the prevalence and clinical significance of coexisting morbidities and the LVEF.

Indexed as

ComorbidityGlobal HealthHeart FailureHumansPrognosisRisk FactorsStroke VolumeVentricular Dysfunction, LeftVentricular Function, LeftAgingCoexisting morbiditiesGenesSexSpectrum

Identifiers

PMID32524363

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.